Valuation: Axogen, Inc.

Market Cap 227.34Cr 198.87Cr 183.39Cr 169.69Cr 322.07Cr 22TCr 327.45Cr 2.2TCr 860.94Cr 11TCr 853.44Cr 834.98Cr 37TCr P/E 2026 *
-110x
P/E 2027 * 277x
Enterprise Value 227.34Cr 198.87Cr 183.39Cr 169.69Cr 322.07Cr 22TCr 327.45Cr 2.2TCr 860.94Cr 11TCr 853.44Cr 834.98Cr 37TCr EV / Sales 2026 *
8.39x
EV / Sales 2027 * 7.14x
Free-Float
96.5%
Yield 2026 *
-
Yield 2027 * -
1 day+2.19%
1 week-4.97%
Current month-5.59%
1 month+1.73%
3 months+32.07%
6 months+30.14%
Current year+33.24%
1 week 42.22
Extreme 42.22
46.95
1 month 40.32
Extreme 40.325
46.95
Current year 27.54
Extreme 27.54
46.95
1 year 11.25
Extreme 11.25
46.95
3 years 3.45
Extreme 3.45
46.95
5 years 3.45
Extreme 3.45
46.95
10 years 3.45
Extreme 3.45
56.85
Manager TitleAgeSince
Chief Executive Officer 66 09/08/2024
Director of Finance/CFO 42 12/05/2025
Chief Operating Officer 65 10/01/2025
Director TitleAgeSince
Director/Board Member 65 01/09/2016
Director/Board Member 58 15/05/2019
Chairman 70 09/08/2024
Date Insider Type Main position Quantity % Market Cap.
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%-4.97%+270.83%+416.71% 227.34Cr
+2.33%-0.55%+23.98%+0.72% 19TCr
-0.84%-3.20%-21.92%+21.19% 15TCr
+2.40%-1.72%-3.20%-17.04% 14TCr
+0.16%-0.91%-56.56%-15.12% 6.66TCr
-2.35%-3.28%+18.25%-0.40% 5.39TCr
+0.38%-1.66%-27.47%-30.84% 4.36TCr
+2.80%+1.18%+9.01%+11.72% 3.65TCr
+2.19%-1.12%+7.39%+41.70% 3.61TCr
+1.20%-0.89%-18.84%-4.09% 2.97TCr
Average +1.08%+0.80%+20.15%+42.46% 7.4TCr
Weighted average by Cap. +1.07%+1.61%-3.29%+1.81%

Financials

2026 *2027 *
Net sales 27Cr 24Cr 22Cr 20Cr 38Cr 2.59TCr 39Cr 261.7Cr 102.59Cr 1.27TCr 101.69Cr 99Cr 4.4TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.04TCr 46Cr 307.62Cr 120.59Cr 1.49TCr 119.54Cr 116.95Cr 5.17TCr
Net income -2.12Cr -1.85Cr -1.71Cr -1.58Cr -3Cr -202.07Cr -3.05Cr -20Cr -8.02Cr -99Cr -7.95Cr -7.78Cr -343.73Cr 80.57L 70.48L 64.99L 60.14L 1.14Cr 77Cr 1.16Cr 7.78Cr 3.05Cr 38Cr 3.02Cr 2.96Cr 130.81Cr
Net Debt - -
Logo Axogen, Inc.
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Employees
622
Date Price Change Volume
10/26/10 $43.66 +2.13% 9,48,049
08/26/08 $42.75 -4.08% 10,52,340
07/26/07 $44.57 -3.05% 12,91,264
06/26/06 $45.97 +0.17% 16,31,968
02/26/02 $45.89 +4.25% 24,09,600
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
42.75USD
Average target price
50.78USD
Spread / Average Target
+18.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AXGN Stock